Inhaled salmeterol or oral theophylline in nocturnal asthma?

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 1, 1997, Pages 104-108

  Selby, Colin ^a   Engleman, Heather M ^a   Fitzpatrick, Michael F ^a   Sime, Patricia M ^a   Mackay, Tom W ^a   Douglas, Neil J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SALMETEROL; THEOPHYLLINE;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; COGNITION; COUGHING; CROSSING OVER; DOSE RESPONSE; EXPIRATORY FLOW; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; SLEEP; TREATMENT PLANNING;

EID: 0031027164     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.1.9001297     Document Type: Article

References (25)

1. Turner-Warwick, M. 1988. Epidemiology of nocturnal asthma. Am. J. Med. 85(Suppl. 1B):6-8.
2. Fitzpatrick, M. F., H. Engleman, K. F. Whyte, I. J. Deary, C. M. Shapiro, and N. J. Douglas. 1991. Morbidity in nocturnal asthma: sleep quality and daytime cognitive performance. Thorax 46:569-573.
3. Douglas, N. J. 1993. Nocturnal asthma. Thorax 48:100-102.
4. British Thoracic Society. Guidelines on the management of asthma. 1993. Thorax 48:S1-S24.
5. Barnes, P. J., A. P. Greening, L. Neville, J. Timmers, and G. W. Poole. 1982. Single-dose slow-release aminophylline at night prevents nocturnal asthma. Lancet i:299-301.
6. 2 agonist. B.M.J. 301:1365-1368.
7. Rhind, G. B., J. J. Connaughton, J. McFie, N. J. Douglas, and D. C. Flenley. 1985. Sustained release choline theophylline in nocturnal asthma. B.M.J. 291:1605-1607.
8. Berry, R. B., M. M. Desa, J. P. Branum, and R. W. Light. 1991. Effect of theophylline on sleep-disordered breathing in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 143: 245-250.
9. Fitzpatrick, M. F., H. M. Engleman, F. Boellert, R. McHardy, C. M. Shapiro, I. J. Deary, and N. J. Douglas. 1992. Effect of therapeutic theophylline levels on the sleep quality and daytime cognitive performance of normal subjects. Am. Rev. Respir. Dis. 145:1355-1358.
10. Veale, D., B. G. Cooper, C. J. Griffiths, P. A. Corris, and G. J. Gibson. 1994. The effect of controlled-release salbutamol on sleep and nocturnal oxygenation in patients with asthma and chronic obstructive pulmonary disease. Respir. Med. 88:121-124.
11. Fjellbirkeland, L., A. Gulsvik, and J. B. D. Palmer. 1994. The efficacy and tolerability of inhaled salmeterol and individually dose-titrated, sustained-release theophylline in patients with reversible airways disease. Respir. Med. 88:599-607.
12. Zigmond, A. S., and R. P. Snaith. 1983. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67:361-370.
13. Boll, T. J. 1981. The Halstead-Reitan neuropsychological battery. In S. B. Filskov and T. J. Boll, editors. Handbook of Clinical Neuropsychology. Wiley, New York. 577-607.
14. Wechsler, D. 1981. Manual for the Wechsler Adult Intelligence Scale (Revised). Psychological Corporation, New York.
15. Gronwall, D. 1977. Paced auditory serial addition test: a measure of recovery from concussion. Percep. Motor Skills 44:367-373.
16. Tiplady, B. 1988. A continuous attention test for the assessment of acute behavioural effects of drugs. Psychopharm. Bull. 24:213-216.
17. Catterall, J. R., N. J. Douglas, P. M. A. Calverley, H. M. Brash, V. Brezinova, and C. M. Shapiro. 1982. Irregular breathing and hypoxaemia during sleep in chronic stable asthma. Lancet i:301-304.
18. Rechtschaffen, A., and A. Kales. 1968. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. U.S. Government Printing Office, Bethesda, MD.
19. Cheshire, K., H. Engleman, I. Deary, C. M. Shapiro, and N. J. Douglas. 1992. Factors impairing daytime performance in patients with sleep apnoea/hypopnoea syndrome. Arch. Intern. Med. 152:538-541.
20. Kaplan, J., P. A. Fredrickson, S. A. Renaux, and P. C. O'Brien. 1993. Theophylline effect on sleep in normal subjects. Chest 103:193-195.
21. Zwillich, C. W., S. R. Neagley, L. Cicutto, D. P. White, and R. J. Martin. 1989. Nocturnal asthma therapy: inhaled bitolterol versus sustained-release theophylline. Am. Rev. Respir. Dis. 139:470-474.
22. Martin, S. E., H. M. Engleman, I. J. Deary, and N. J. Douglas. 1996. The effect of sleep fragmentation on daytime function. Am. J. Respir. Crit. Care Med. 153:1328-1332.
23. Yu, G., V. Maskray, S. Jackson, C. G. Swift, and B. Tiplady. 1991. A comparison of the central nervous system effects of caffeine and theophylline in elderly subjects. Br. J. Clin. Pharmacol. 32:341-345.
24. Woodcock, A. A., M. A. Johnson, and D. M. Geddes. 1983. Theophylline prescribing, serum concentrations, and toxicity. Lancet i:610-613.
25. Barnes, P. J., and R. A. Pauwels. 1994. Theophylline in the management of asthma: time for reappraisal? Eur. Respir. J. 7:579-591.